A detailed history of Israel Englander (Millennium Management LLC) transactions in Ikena Oncology, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 249,417 shares of IKNA stock, worth $424,008. This represents 0.0% of its overall portfolio holdings.

Number of Shares
249,417
Previous 354,710 29.68%
Holding current value
$424,008
Previous $585,000 26.32%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.6 - $1.85 $168,468 - $194,792
-105,293 Reduced 29.68%
249,417 $431,000
Q2 2024

Aug 14, 2024

BUY
$1.24 - $1.82 $439,840 - $645,572
354,710 New
354,710 $585,000
Q1 2023

May 15, 2023

BUY
$2.62 - $4.97 $258,544 - $490,444
98,681 Added 967.56%
108,880 $376,000
Q4 2022

Feb 14, 2023

BUY
$2.0 - $3.7 $20,398 - $37,736
10,199 New
10,199 $27,000

Others Institutions Holding IKNA

About Ikena Oncology, Inc.


  • Ticker IKNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,257,500
  • Market Cap $61.6M
  • Description
  • Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...
More about IKNA
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.